DR. REDDY S LABORATORIES vs MANKIND PHARMA LIMITED
A side-by-side comparison of DR. REDDY S LABORATORIES (DRREDDY) and MANKIND PHARMA LIMITED (MANKIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, DR. REDDY S LABORATORIES leads DRREDDY vs MANKIND on 7 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company's working capital requirements have reduced from 85.1 days to 67.8 days"]
- − ["Dividend payout has been low at 13.2% of profits over last 3 years"]
- + ["Company has reduced debt."]
- − ["Promoter holding has decreased over last 3 years: -3.84%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.